Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Oct 14

PMID 26461935

Citations 13

Authors

Zenaida P Lopez-Dee

Sridar V Chittur

Hiral Patel

Aleona Chinikaylo

Brittany Lippert

Bhumi Patel

Jack Lawler

Linda S Gutierrez

Affiliations

Soon will be listed here.

Abstract

Colorectal Cancer (CRC) is one of the late complications observed in patients suffering from inflammatory bowel diseases (IBD). Carcinogenesis is promoted by persistent chronic inflammation occurring in IBD. Understanding the mechanisms involved is essential in order to ameliorate inflammation and prevent CRC. Thrombospondin 1 (TSP-1) is a multidomain glycoprotein with important roles in angiogenesis. The effects of TSP-1 in colonic tumor formation and growth were analyzed in a model of inflammation-induced carcinogenesis. WT and TSP-1 deficient mice (TSP-1-/-) of the C57BL/6 strain received a single injection of azoxymethane (AOM) and multiple cycles of dextran sodium sulfate (DSS) to induce chronic inflammation-related cancers. Proliferation and angiogenesis were histologically analyzed in tumors. The intestinal transcriptome was also analyzed using a gene microarray approach. When the area containing tumors was compared with the entire colonic area of each mouse, the tumor burden was decreased in AOM/DSS-treated TSP-1-/- versus wild type (WT) mice. However, these lesions displayed more angiogenesis and proliferation rates when compared with the WT tumors. AOM-DSS treatment of TSP-1-/- mice resulted in significant deregulation of genes involved in transcription, canonical Wnt signaling, transport, defense response, regulation of epithelial cell proliferation and metabolism. Microarray analyses of these tumors showed down-regulation of 18 microRNAs in TSP-1-/- tumors. These results contribute new insights on the controversial role of TSP-1 in cancer and offer a better understanding of the genetics and pathogenesis of CRC.

Citing Articles

THBS1 and THBS2 Enhance the In Vitro Proliferation, Adhesion, Migration and Invasion of Intrahepatic Cholangiocarcinoma Cells.

Corbella E, Fara C, Covarelli F, Porreca V, Palmisano B, Mignogna G Int J Mol Sci. 2024; 25(3).

PMID: 38339060 PMC: 10855656. DOI: 10.3390/ijms25031782.

Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1.

Thuring E, Hartmann C, Maddumage J, Javorsky A, Michels B, Gerke V Commun Biol. 2023; 6(1):702.

PMID: 37430142 PMC: 10333293. DOI: 10.1038/s42003-023-05088-3.

TMIGD1: Emerging functions of a tumor supressor and adhesion receptor.

Thuring E, Hartmann C, Schwietzer Y, Ebnet K Oncogene. 2023; 42(22):1777-1785.

PMID: 37087524 PMC: 10238269. DOI: 10.1038/s41388-023-02696-5.

miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI.

Soheilifar M, Pornour M, Saidijam M, Najafi R, Jalilian F, Keshmiri Neghab H Bioimpacts. 2022; 12(4):349-358.

PMID: 35975203 PMC: 9376166. DOI: 10.34172/bi.2021.23571.

Paracrine signalling between intestinal epithelial and tumour cells induces a regenerative programme.

Jacquemin G, Wurmser A, Huyghe M, Sun W, Homayed Z, Merle C Elife. 2022; 11.

PMID: 35543624 PMC: 9094746. DOI: 10.7554/eLife.76541.

References

Bossard C, Souaze F, Jarry A, Bezieau S, Mosnier J, Forgez P . Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis. Peptides. 2007; 28(10):2030-5. DOI: 10.1016/j.peptides.2007.06.030. View

Zhou L, Picard D, Ra Y, Li M, Northcott P, Hu Y . Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma. Cancer Res. 2010; 70(20):8199-210. DOI: 10.1158/0008-5472.CAN-09-4562. View

Kerr C, Hines B, Shaw J, Dunne R, Bragg L, Clarke J . Genomic homeostasis is dysregulated in favour of apoptosis in the colonic epithelium of the azoxymethane treated rat. BMC Physiol. 2013; 13:2. PMC: 3561103. DOI: 10.1186/1472-6793-13-2. View

Zhang D, Zeldin D, Blackshear P . Regulatory factor X4 variant 3: a transcription factor involved in brain development and disease. J Neurosci Res. 2007; 85(16):3515-22. PMC: 2367213. DOI: 10.1002/jnr.21356. View

De Robertis M, Massi E, Poeta M, Carotti S, Morini S, Cecchetelli L . The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog. 2011; 10:9. PMC: 3072657. DOI: 10.4103/1477-3163.78279. View

Alkim C, Sakiz D, Alkim H, Livaoglu A, Kendir T, Demirsoy H . Thrombospondin-1 and VEGF in inflammatory bowel disease. Libyan J Med. 2012; 7. PMC: 3269884. DOI: 10.3402/ljm.v7i0.8942. View

Oue N, Matsumura S, Nakayama H, Kitadai Y, Taniyama K, Matsusaki K . Reduced expression of the TSP1 gene and its association with promoter hypermethylation in gastric carcinoma. Oncology. 2003; 64(4):423-9. DOI: 10.1159/000070302. View

Reubi J, Waser B, Schaer J, Markwalder R . Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab. 1995; 80(9):2806-14. DOI: 10.1210/jcem.80.9.7673428. View

Lopez-Dee Z, Pidcock K, Gutierrez L . Thrombospondin-1: multiple paths to inflammation. Mediators Inflamm. 2011; 2011:296069. PMC: 3134184. DOI: 10.1155/2011/296069. View

10.

Luo Z, Zhang L, Li Z, Li X, Li G, Yu H . An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics. 2012; 5:3. PMC: 3293045. DOI: 10.1186/1755-8794-5-3. View

11.

Borinstein S, Conerly M, Dzieciatkowski S, Biswas S, Washington M, Trobridge P . Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Mol Carcinog. 2009; 49(1):94-103. PMC: 2875385. DOI: 10.1002/mc.20581. View

12.

Li Q, Ahuja N, Burger P, Issa J . Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene. 1999; 18(21):3284-9. DOI: 10.1038/sj.onc.1202663. View

13.

Lawler J, Miao W, Duquette M, BOUCK N, Bronson R, Hynes R . Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am J Pathol. 2001; 159(5):1949-56. PMC: 1867067. DOI: 10.1016/S0002-9440(10)63042-8. View

14.

Lan Y, Ovitt C, Cho E, Maltby K, Wang Q, Jiang R . Odd-skipped related 2 (Osr2) encodes a key intrinsic regulator of secondary palate growth and morphogenesis. Development. 2004; 131(13):3207-16. DOI: 10.1242/dev.01175. View

15.

Gui X, Liu S, Yan Y, Gao Z . Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia. World J Gastroenterol. 2013; 19(28):4504-10. PMC: 3725374. DOI: 10.3748/wjg.v19.i28.4504. View

16.

Kazerounian S, Duquette M, Reyes M, Lawler J, Song K, Perruzzi C . Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase. Blood. 2011; 117(17):4658-66. PMC: 3099580. DOI: 10.1182/blood-2010-09-305284. View

17.

Kawai S, Amano A . Negative regulation of Odd-skipped related 2 by TGF-beta achieves the induction of cellular migration and the arrest of cell cycle. Biochem Biophys Res Commun. 2012; 421(4):696-700. DOI: 10.1016/j.bbrc.2012.04.064. View

18.

Gutierrez L, Suckow M, Lawler J, Ploplis V, Castellino F . Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model. Carcinogenesis. 2003; 24(2):199-207. DOI: 10.1093/carcin/24.2.199. View

19.

Patel Y . Somatostatin and its receptor family. Front Neuroendocrinol. 1999; 20(3):157-98. DOI: 10.1006/frne.1999.0183. View

20.

Furukawa S, Kawasaki Y, Miyamoto M, Hiyoshi M, Kitayama J, Akiyama T . The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration. PLoS One. 2013; 8(11):e80609. PMC: 3823710. DOI: 10.1371/journal.pone.0080609. View